P. Chetchotisakd

发表

Risk factors for melioidosis and bacteremic melioidosis.

Y. Suputtamongkol, W. Chaowagul, P. Mootsikapun, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

International collaboration between US and Thailand on a clinical trial of treatment for HIV-associated cryptococcal meningitis.

P. Pappas, T. Nolen, P. Chetchotisakd, 2010, Contemporary clinical trials.

Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.

P. Chetchotisakd, A. Lulitanond, C. Wilailuckana, 2012, The Journal of antimicrobial chemotherapy.

A qualitative assessment of barriers and facilitators to antiretroviral adherence in Thai patients

P. Phanuphak, S. Kerr, A. Sohn, 2016, Journal of virus eradication.

Low-dose, once-daily atazanavir/ritonavir (200/100): an effective treatment for HIV-infected patients in Thailand.

P. Chetchotisakd, S. Anunnatsiri, 2008, Journal of acquired immune deficiency syndromes.

Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients

K. Ruxrungtham, A. Birnbaum, T. Bunupuradah, 2021, Expert review of clinical pharmacology.

Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients.

K. Ruxrungtham, S. Emery, T. Bunupuradah, 2019, Pharmacogenomics.

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

D. Pittet, J. Decruyenaere, C. Barrios, 2007, The Lancet.

Evaluation of plasma anti-GPL-core IgA and IgG for diagnosis of disseminated non-tuberculous mycobacteria infection

Chidchamai Kewcharoenwong, Arnone Nithichanon, G. Lertmemongkolchai, 2020, PloS one.

Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the US.

S. Holland, Lindsey B. Rosen, C. Zerbe, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Differentiation between persistent infection/colonization and re-infection/re-colonization of Mycobacterium abscessus isolated from patients in Northeast Thailand.

V. Lulitanond, P. Chetchotisakd, W. Namwat, 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand

V. Lulitanond, P. Chetchotisakd, W. Namwat, 2018, PloS one.

Epidemiology of and risk factors for extrapulmonary nontuberculous mycobacterial infections in Northeast Thailand

P. Chetchotisakd, K. Faksri, W. Reechaipichitkul, 2018, PeerJ.

Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity.

T. Davis, A. Chaiprasert, L. Wheat, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Non-HIV-infected Man with Multiple Infections: Mycobacterium abscessus Lymphadenitis, Pulmonary Cryptococcosis and Tuberculous Osteomyelitis

Pornrith Pisuttimarn, P. Chetchotisakd, 2010 .

Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand.

R. Chaiwarith, P. Mootsikapun, P. Chetchotisakd, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibiotic Susceptibility of Clinical Burkholderia pseudomallei Isolates in Northeast Thailand from 2015 to 2018 and the Genomic Characterization of β-Lactam-Resistant Isolates

T. West, W. Chantratita, N. Day, 2021, Antimicrobial Agents and Chemotherapy.

Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA

Arnone Nithichanon, G. Lertmemongkolchai, M. Ato, 2020, Scientific Reports.

Adult-onset immunodeficiency in Thailand and Taiwan.

Smita Y. Patel, M. Iadarola, S. Holland, 2012, The New England journal of medicine.

Clinical features and outcomes of Sweet's syndrome associated with non‐tuberculous mycobacterial infection and other associated diseases

K. Sawanyawisuth, C. Choonhakarn, P. Chetchotisakd, 2016, The Journal of dermatology.

Assessment of bacterial cross-transmission as a cause of infections in patients in intensive care units.

P. Chetchotisakd, A. Hartstein, C. Phelps, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

No change in calculated creatinine clearance after tenofovir initiation among Thai patients.

Michelle Le Braz, B. Hirschel, J. Ananworanich, 2007, The Journal of antimicrobial chemotherapy.

HIV Drug Therapy in the Americas 16–18 April 2015, Mexico City, Mexico

M. Lederman, D. Podzamczer, D. Kuritzkes, 2015, Journal of the International AIDS Society.

Immune Control of Burkholderia pseudomallei––Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes

John H. Robinson, D. Altmann, R. Boyton, 2018, Front. Immunol..

Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial.

Kimberly Smith, M. Aboud, R. Kaplan, 2019, The Lancet. Infectious diseases.

Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis.

S. Filler, W. Manosuthi, P. Pappas, 2009, International journal of antimicrobial agents.

Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial.

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2016, The lancet. HIV.

Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.

F. Antunes, J. Gallant, J. Fehr, 2013, The Journal of infectious diseases.

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients

P. Chetchotisakd, 2009, Expert review of anti-infective therapy.

Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated Mycobacterium abscessus Infection

Arnone Nithichanon, G. Lertmemongkolchai, P. Chetchotisakd, 2018, Journal of immunology research.

Linezolid in the treatment of disseminated nontuberculous mycobacterial infection in anti-interferon-gamma autoantibody-positive patients.

P. Chetchotisakd, S. Anunnatsiri, 2014, The Southeast Asian journal of tropical medicine and public health.

Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1–Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study

J. Absalon, J. Molina, G. Moyle, 2010, Journal of acquired immune deficiency syndromes.

Immune Reconstitution Inflammatory Syndrome after Antiretroviral Therapy in AIDS Patients with Cryptococcal Meningitis : A Prospective Multicenter Study

J. Sobel, S. Filler, A. Kendrick, 2009 .

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.

J. Sobel, S. Filler, A. Kendrick, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of changes in diagnosis and management of active infective endocarditis on the clinical outcome at Srinagarind Hospital.

S. Kiatchoosakun, P. Chetchotisakd, O. Pachirat, 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Antilipopolysaccharide II: an antibody protective against fatal melioidosis.

Y. Suputtamongkol, W. Chaowagul, D. Woods, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand.

P. Chetchotisakd, C. Wanke, S. Anunnatsiri, 2005, The Southeast Asian journal of tropical medicine and public health.

A rapidly fatal case of Panton-valentine leukocidin positive Staphylococcus aureus necrotizing pneumonia in an HIV-infected patient.

P. Chetchotisakd, Jaluporn Chumpol, S. Anunnatsiri, 2007, The Southeast Asian journal of tropical medicine and public health.

Superior Efficacy of Dolutegravir (DTG) Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Compared with lopinavir/ritonavir (LPV/r) Plus 2 NRTIs in Second-Line Treatment — 48-week Data from the DAWNING Study

J. Gatell, Kimberly Smith, M. Aboud, 2019, Journal of Infection and Public Health.

Infective endocarditis: prevalence, characteristics and mortality in Khon Kaen, 1990-1999.

P. Chetchotisakd, O. Pachirat, C. Tantisirin, 2002, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Clinical and epidemiological analyses of human pythiosis in Thailand.

S. Kalnauwakul, T. Krajaejun, R. Chaiwarith, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

J. Perfect, G. Rahav, F. Marty, 2016, The Lancet. Infectious diseases.

Use of a low-dose steroid as an adjunct in the treatment, in mice, of severe sepsis caused by Burkholderia pseudomallei

P. Chetchotisakd, R. Sermswan, S. Wongratanacheewin, 2009, Annals of tropical medicine and parasitology.

HAEMOPHILUS INFLUENZAE INFECTED ATRIAL MYXOMA : A CASE REPORT

P. Chetchotisakd, T. Sasiprapha, 2018 .

Phenotypic and Functional Characterization of Human Memory T Cell Responses to Burkholderiapseudomallei

G. Bancroft, G. Lertmemongkolchai, R. Titball, 2009 .

Fungemia in non-HIV-infected patients: a five-year review.

P. Mootsikapun, P. Chetchotisakd, S. Anunnatsiri, 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.

J. Sobel, G. Rahav, C. Viscoli, 2018, Clinical Infectious Diseases.

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

T. Griffin, R. Dewar, J. Metcalf, 2017, Open forum infectious diseases.

A multicentre, randomized, double‐blind, placebo‐controlled trial of primary cryptococcal meningitis prophylaxis in HIV‐infected patients with severe immune deficiency

B. Thinkhamrop, P. Mootsikapun, P. Chetchotisakd, 2004, HIV medicine.

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

K. Lichtenstein, F. Post, Samir K. Gupta, 2016, Journal of acquired immune deficiency syndromes.

Serological diagnosis of pulmonary Mycobacterium tuberculosis infection by LIPS using a multiple antigen mixture

S. Holland, J. Kovacs, S. Browne, 2015, BMC Microbiology.

Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis.

B. Thinkhamrop, P. Mootsikapun, P. Chetchotisakd, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

Brief Report: Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results

F. Antunes, J. Gallant, J. Fehr, 2015, Journal of acquired immune deficiency syndromes.

A Prospective Study of Efficacy and Safety of Once-Daily Saquinavir/Ritonavir plus Two Nucleoside Reverse Transcriptase Inhibitors in Treatment-Naive Thai Patients

B. Hirschel, J. Ananworanich, R. Nuesch, 2005, Antiviral therapy.

Characteristics and one year outcomes of melioidosis patients in Northeastern Thailand: a prospective, multicenter cohort study

T. West, G. Lertmemongkolchai, N. Chantratita, 2022, The Lancet regional health. Southeast Asia.

A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis.

J. Sobel, S. Filler, A. Kendrick, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV‐associated cryptococcal meningitis‐infected patients

S. Filler, D. Andes, W. Manosuthi, 2010, HIV medicine.

Factors associated with severe manifestations of histoplasmosis in AIDS.

K. Shutt, R. Hajjeh, L. Wheat, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cryptococcosis in Anti-Interferon-Gamma Autoantibody-Positive Patients: a Different Clinical Manifestation from HIV-Infected Patients.

Arnone Nithichanon, G. Lertmemongkolchai, P. Chetchotisakd, 2017, Japanese journal of infectious diseases.

Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.

A. Vibhagool, A. Ingsathit, P. Mootsikapun, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rhinocerebral mucormycosis: a report of eleven cases.

C. Pairojkul, P. Chetchotisakd, P. Boonma, 1991, The Southeast Asian journal of tropical medicine and public health.

Human pythiosis in Srinagarind Hospital: one year's experience.

C. Pairojkul, M. Haswell-Elkins, A. Chaiprasert, 1992, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Disseminated coccidioidomycosis in an AIDS patient presented with nasal mass

P. Chetchotisakd, Sukanya Srigulbutr, Khanungnit Semram, 2011 .

Anti-IFN-γ autoantibodies are strongly associated with HLA-DR*15:02/16:02 and HLA-DQ*05:01/05:02 across Southeast Asia.

J. Casanova, K. Yuen, S. Holland, 2016, The Journal of allergy and clinical immunology.

High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand.

P. Chetchotisakd, A. Lulitanond, C. Wilailuckana, 2016, Diagnostic microbiology and infectious disease.

Molecular Characterization of Carbapenemase-Nonproducing Clinical Isolates of Escherichia coli (from a Thai University Hospital) with Reduced Carbapenem Susceptibility.

P. Chetchotisakd, A. Lulitanond, C. Wilailuckana, 2017, Japanese journal of infectious diseases.

Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand

K. Ruxrungtham, P. Phanuphak, M. Leechawengwongs, 2015, AIDS Research and Therapy.

Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States

Lindsey B. Rosen, S. Hunsberger, P. Mootsikapun, 2020 .

Mycotic aneurysm in Northeast Thailand: the importance of Burkholderia pseudomallei as a causative pathogen.

P. Chetchotisakd, C. Kularbkaew, S. Anunnatsiri, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increasing Incidence of Human Melioidosis in Northeast Thailand

N. Day, S. Peacock, W. Chaowagul, 2010, The American journal of tropical medicine and hygiene.

Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis.

A. Cheng, S. Peacock, W. Chaowagul, 2008, The American journal of tropical medicine and hygiene.

Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial

N. Day, S. Peacock, W. Chaowagul, 2014, The Lancet.

Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis.

P. Newton, A. Simpson, A. Cheng, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination.

B. Thinkhamrop, P. Chetchotisakd, S. Wongratanacheewin, 2000, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline.

W. Chaowagul, P. Mootsikapun, P. Chetchotisakd, 2001, The American journal of tropical medicine and hygiene.

A Comparison Between 12 Versus 20 Weeks of Trimethoprim-sulfamethoxazole as Oral Eradication Treatment for Melioidosis: An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial

N. Day, W. Chaowagul, W. Chierakul, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit.

N. Day, S. Peacock, W. Chaowagul, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand

N. Day, P. Cheah, S. Peacock, 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand.

N. Day, P. Cheah, S. Peacock, 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Erratum to Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand [Trans R Soc Trop Med Hyg, 109, (2015), 416-418]

N. Day, P. Cheah, S. Peacock, 2015 .

Phenotypic and Functional Characterization of Human Memory T Cell Responses to Burkholderia pseudomallei

G. Bancroft, G. Lertmemongkolchai, R. Titball, 2009, PLoS neglected tropical diseases.

Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2008, AIDS.

CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial

Matthias Cavassini, Urs Karrer, Hansjakob Furrer, 2006, The Lancet.

Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials

H. Stellbrink, A. Lazzarin, P. Williams, 2013, AIDS.

Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008.

Somnuek Sungkanuparph, Khuanchai Supparatpinyo, S. Suwanagool, 2008, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star Study

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2012, Antiviral therapy.

Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial.

H. Jessen, A. Winston, D. Cooper, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Improvement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemia

P. Mootsikapun, P. Chetchotisakd, S. Anunnatsiri, 2016, HIV clinical trials.

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

J. Molina, G. Moyle, M. Mancini, 2008, The Lancet.

Long-Term Efficacy and Safety of First-Line Therapy with Once-Daily Saquinavir/Ritonavir

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2007, Antiviral therapy.

P029: Safety of tenofovir alafenamide in renal impairment

K. Lichtenstein, F. Post, Samir K. Gupta, 2015 .

Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis.

A. Vibhagool, W. Chantratita, P. Mootsikapun, 2003, Journal of acquired immune deficiency syndromes.

Efficacy and Safety of Indinavir/Ritonavir 400/100 mg Twice Daily plus Two Nucleoside Analogues in Treatment-Naive HIV-1-Infected Patients with CD4+ T-cell Counts <200 cells/mm3: 96-Week Outcomes

P. Mootsikapun, P. Chetchotisakd, S. Anunnatsiri, 2005, Antiviral therapy.

877 Mootsikapun

P. Mootsikapun, P. Chetchotisakd, S. Anunnatsiri, 2005 .

Whole-Genome Sequencing and Drug-Susceptibility Analysis of Serial Mycobacterium abscessus Isolates from Thai Patients

P. Chetchotisakd, W. Namwat, K. Faksri, 2022, Biology.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

TLR4 genetic variation is associated with inflammatory responses in Gram-positive sepsis.

T. West, M. Emond, N. Chantratita, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The Impact of Combination Antiretroviral Therapy and its Interruption on Anxiety, Stress, Depression and Quality of Life in Thai Patients

B. Hirschel, K. Ruxrungtham, A. Gayet-Ageron, 2009, The open AIDS journal.

Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study.

D. Cooper, H. Teppler, S. Emery, 2016, AIDS research and human retroviruses.

WEST AND OTHERS SEVERE STAPHYLOCOCCAL SEPSIS IN THAILAND Patient Characteristics, Management, and Predictors of Outcome from Severe Community-Onset Staphylococcal Sepsis in Northeast Thailand: A Prospective Multicenter Study

Sharon, Srisamang, N. Chantratita, 2018 .

Patient Characteristics, Management, and Predictors of Outcome from Severe Community-Onset Staphylococcal Sepsis in Northeast Thailand: A Prospective Multicenter Study

T. West, S. Peacock, N. Chantratita, 2017, The American journal of tropical medicine and hygiene.

Body composition in adults infected with human immunodeficiency virus in Khon Kaen, Thailand.

R. Houser, P. Mootsikapun, P. Chetchotisakd, 2005, The American journal of tropical medicine and hygiene.

Virological outcomes and metabolic effects after switching from ritonavir-boosted protease inhibitors to a dolutegravir-based regimen in virologically suppressed patients living with HIV

P. Chetchotisakd, A. Meesing, Wantin Sribenjalux, 2022, International journal of STD & AIDS.

Pilot study of a non-return catheter valve for reducing catheter-associated urinary tract infections in critically ill patients.

P. Chetchotisakd, C. Hurst, Suranut Charoensri, 2015, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial

T. West, B. Cooper, Yie Hui Lau, 2021, BMJ Open.

Absence of Resistance Mutations in Antiretroviral-Naive Patients Treated with Ritonavir-Boosted Saquinavir

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2005, Antiviral therapy.

Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus

Auttawit Sirichoat, S. Roytrakul, P. Chetchotisakd, 2021, PloS one.

Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV‐infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors

K. Ruxrungtham, P. Mootsikapun, P. Chetchotisakd, 2007, HIV medicine.

Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2012, Journal of NeuroVirology.

Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial

H. Jessen, D. Duprez, K. H. Hullsiek, 2016, Open forum infectious diseases.

Comparison of community-onset Staphylococcus argenteus and Staphylococcus aureus sepsis in Thailand: a prospective multicentre observational study

T. West, N. Chantratita, P. Chetchotisakd, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis

A. Vibhagool, P. Mootsikapun, P. Chetchotisakd, 2003, AIDS.

High Rate Multiple Drug Resistances in HIV-Infected Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor Regimens in Thailand, Where Subtype A/E is Predominant

K. Ruxrungtham, P. Chetchotisakd, S. Kiertiburanakul, 2006, Journal of the International Association of Physicians in AIDS Care.

Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients

S. Filler, A. Kendrick, W. Manosuthi, 2011, International journal of STD & AIDS.

Etravirine and Rilpivirine Resistance in HIV-1 Subtype Crf01_Ae-Infected Adults Failing Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2011, Antiviral therapy.

Varicella zoster meningitis following COVID-19 vaccination: a report of two cases

P. Mootsikapun, P. Chetchotisakd, P. Kotruchin, 2022, International Journal of Infectious Diseases.

Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy

D. Cooper, P. Phanuphak, S. Emery, 2017, The lancet. HIV.

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study

K. Ruxrungtham, F. Struyf, G. Dubin, 2020, EClinicalMedicine.

Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials

Tak-Lam Wong, A. Avihingsanon, P. Chetchotisakd, 2022, HIV medicine.

Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

Henrik Nielsen, L. Mathiesen, C. Leen, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical outcome of native valve infective endocarditis in Khon Kaen: 1990-1999.

P. Chetchotisakd, O. Pachirat, S. Limwattananon, 2002, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Pulmonary infections in HIV infected patients.

P. Mootsikapun, P. Chetchotisakd, B. Intarapoka, 1996, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Pooled Week 96 efficacy, resistance and safety results from the double-blind, randomised, Phase III trials comparing rilpivirine (RPV, TMC278) versus efavirenz (EFV) in treatment-naïve, HIV-1-infected adults

H. Stellbrink, A. Lazzarin, P. Williams, 2011 .

Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir

P. Chetchotisakd, Supphachoke Khemla, A. Meesing, 2023, Drug target insights.

[Tuberculous pericarditis].

Soloff, P. Chetchotisakd, Churairat Kularbkaew, 1949, Arquivos brasileiros de medicina.

Pulmonary melioidosis presenting with a lung mass undifferentiated from cancer: a case report.

P. Chetchotisakd, S. Prathanee, C. Kularbkaew, 2000 .

Non-HACEK Gram-Negative Bacillus Endocarditis

Pierre Tattevin, Francisco Nacinovich, John Klein, 2007, Annals of Internal Medicine.

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV

T. Harrer, A. Winston, E. Harrer, 2023, Scientific Reports.

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.

J. Sobel, S. Filler, W. Manosuthi, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cefoperazone/sulbactam + co-trimoxazole vs ceftazidime + co-trimoxazole in the treatment of severe melioidosis: a randomized, double-blind, controlled study.

B. Thinkhamrop, P. Chetchotisakd, S. Thamprajamchit, 1998, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis.

B. Thinkhamrop, P. Mootsikapun, P. Chetchotisakd, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Assessing adherence in Thai patients taking combination antiretroviral therapy

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2012, International journal of STD & AIDS.

Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial.

C. Kityo, V. Pokrovsky, A. Avihingsanon, 2019, Journal of acquired immune deficiency syndromes.

Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA

Arnone Nithichanon, G. Lertmemongkolchai, M. Ato, 2020, Scientific Reports.

J. Molina, G. Moyle, M. Mancini, 2008, The Lancet.

Predictive Validity of the qSOFA Score for Sepsis in Adults with Community-Onset Staphylococcal Infection in Thailand

D. Angus, T. West, S. Peacock, 2019, Journal of clinical medicine.

Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand.

R. Chaiwarith, P. Mootsikapun, P. Chetchotisakd, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High rate of reinfection and possible transmission of Mycobacterium avium complex in Northeast Thailand

Arnone Nithichanon, Auttawit Sirichoat, V. Lulitanond, 2022, One health.

A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star Study

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2012 .

Cryptococcosis in Anti-Interferon-Gamma Autoantibody-Positive Patients: a Different Clinical Manifestation from HIV-Infected Patients.

Arnone Nithichanon, G. Lertmemongkolchai, P. Chetchotisakd, 2017, Japanese journal of infectious diseases.

Mycotic aneurysm in Northeast Thailand: the importance of Burkholderia pseudomallei as a causative pathogen.

P. Chetchotisakd, C. Kularbkaew, S. Anunnatsiri, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Randomized Double-Blind Phase 2 Study of Combination Antivirals for the Treatment of Influenza

M. Hughes, R. Schooley, R. Davey, 2017, The Lancet. Infectious diseases.

Invariant Natural Killer T (iNKT) cells response in human melioidosis.

Pornrith Pisuttimarn, P. Chetchotisakd, R. Sermswan, 2021, Asian Pacific journal of allergy and immunology.

Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.

F. Antunes, J. Gallant, J. Fehr, 2013, The Journal of infectious diseases.

Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008.

S. Suwanagool, K. Ruxrungtham, M. Leechawengwongs, 2008, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.